Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 3,5-Dimethylpyrazole | HCID 6210 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 2-Chloro-N-(4-chlorophenyl)-9-methyl-9H-purin-6-amine | HCID 59293637 | — |
| Solvent | Water | HCID 962 | — |
| Product | NS13001 | HCID 44472568 | 13.3% |
Reaction Steps
Sodium hydride (60% in mineral oil, 160 mg, 4.1 mmol) was added to 3,5-dimethylpyrazole (320 mg, 3.4 mmol) dissolved N,N-dimethylformamide (10 mL) and the mixture was stirred for 30 min. (2-Chloro-9-methyl-9H-purin-6-yl)-(4-chloro-phenyl)amine (1.0 g 3.40 mmol) was added and the reaction mixture was heated at 120° C. for 4 days, cooled down and poured into water. The aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over magnesium sulphate, filtered and concentrated in vacuo. The crude product was purified by flash chromatography (dichloromethane/methanol/ammonia) to give (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-amine (160 mg, 13%) as a yellow crystalline compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09340544B2 |
|---|
| Source dataset | uspto-grants-2016_05 |
|---|
| ORD ID | ord-0d5a01cf826442e6872b8227d4fb6eb4 |
|---|
| Source note | uspto-grants-2016_05 |
|---|